You are here
AusPAR: Olaparib
Related information
How to access a pdf or Word document
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
Australian Public Assessment Report
30 October 2019
| AusPAR | |
|---|---|
| Active Ingredient | Olaparib
|
| Product Name | Lynparza
|
| Sponsor | AstraZeneca Pty Ltd
|
| Submission Number | PM-2017-01451-1-4
|
| Submission Type | Extension of indications and major variation (strength and dosage form)
|
| Decision | Approved
|
| AusPAR Date | 16 October 2019
|
| Publication Date | 30 October 2019 |